StockNews.com began coverage on shares of Milestone Scientific (NYSE:MLSS – Free Report) in a research report sent to investors on Saturday. The firm issued a hold rating on the stock.
Separately, Benchmark restated a “speculative buy” rating and set a $1.25 price target on shares of Milestone Scientific in a research report on Wednesday, November 20th.
Read Our Latest Report on MLSS
Milestone Scientific Stock Up 5.3 %
Insider Activity
In other news, Director Leonard Osser sold 107,984 shares of the stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $0.93, for a total value of $100,425.12. Following the transaction, the director now owns 4,606,882 shares of the company’s stock, valued at $4,284,400.26. This represents a 2.29 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 24.75% of the company’s stock.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently added to or reduced their stakes in MLSS. Y Intercept Hong Kong Ltd purchased a new stake in Milestone Scientific during the third quarter valued at about $48,000. World Investment Advisors LLC bought a new position in shares of Milestone Scientific during the 3rd quarter valued at about $91,000. Finally, Geode Capital Management LLC raised its holdings in shares of Milestone Scientific by 6.4% during the 3rd quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock valued at $480,000 after buying an additional 31,572 shares in the last quarter. 5.79% of the stock is currently owned by hedge funds and other institutional investors.
Milestone Scientific Company Profile
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Further Reading
- Five stocks we like better than Milestone Scientific
- Best Aerospace Stocks Investing
- 3 Must-Hold Stocks with Double-Digit Upside for 2025
- Using the MarketBeat Dividend Tax Calculator
- Micron: Why Now Is the Time to Be Brave
- High Flyers: 3 Natural Gas Stocks for March 2022
- 3 Stocks That Wall Street Insiders Can’t Stop Buying
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.